# EDGAR Filing Document

**Accession Number:** 0001811744
**File Stem:** 0001104659-25-103689
**Filing Date:** 2025-10
**Character Count:** 19790
**Document Hash:** 57a40c2b34526f74942a7bc7da26bf31
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-103689.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0001104659-25-103689

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CalciMedica, Inc.
- **CENTRAL INDEX KEY:** 0001534133
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 452120079
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-91725
- **FILM NUMBER:** 251429593

**BUSINESS ADDRESS:**
- **STREET 1:** 505 COAST BOULEVARD SOUTH
- **STREET 2:** SUITE 307
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037
- **BUSINESS PHONE:** 858-952-5500

**MAIL ADDRESS:**
- **STREET 1:** 505 COAST BOULEVARD SOUTH
- **STREET 2:** SUITE 307
- **CITY:** LA JOLLA
- **STATE:** CA
- **ZIP:** 92037

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CalciMedica, Inc. /DE/
- **DATE OF NAME CHANGE:** 20230322

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAYBUG VISION, INC.
- **DATE OF NAME CHANGE:** 20170717

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GRAYBUG, Inc.
- **DATE OF NAME CHANGE:** 20150303
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bering Partners II GP, L.L.C.
- **CENTRAL INDEX KEY:** 0001811744

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**BUSINESS ADDRESS:**
- **STREET 1:** ONE MARITIME PLAZA
- **STREET 2:** SUITE 2250
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111
- **BUSINESS PHONE:** 650-387-5779

**MAIL ADDRESS:**
- **STREET 1:** ONE MARITIME PLAZA
- **STREET 2:** SUITE 2250
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94111

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** CalciMedica, Inc.

**Title of Class of Securities:** Common Stock, par value $0.0001 per share

**CUSIP Number:** 38942Q202

**Date of Event Which Requires Filing of this Statement:** 01/23/2024

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>Bering Partners II, L.P. ("Bering II") | Names of Reporting Persons<br>Bering Partners II, L.P. ("Bering II") |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>663246.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>663246.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.8% | Percent of Class Represented by Amount in Row (9)<br>5.8% |
| 12. | Type of Reporting Person (See Instructions)<br>PN | Type of Reporting Person (See Instructions)<br>PN |

**Comment for Type of Reporting Person:** Note to row 5, 7 and 9: 663,246 shares, except that Bering Partners II GP, L.L.C., the general partner of Bering II ("Bering II GP"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Bering II and Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer"), the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

---

| 1. | Names of Reporting Persons<br>Bering Partners II GP, L.L.C. ("Bering II GP") | Names of Reporting Persons<br>Bering Partners II GP, L.L.C. ("Bering II GP") |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>663246.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>663246.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.8% | Percent of Class Represented by Amount in Row (9)<br>5.8% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** Note to row 5, 7 and 9: 663,246 shares, of which all are directly owned by Bering II.  Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares.  Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

---

| 1. | Names of Reporting Persons<br>Evgeny Zaytsev ("Zaytsev") | Names of Reporting Persons<br>Evgeny Zaytsev ("Zaytsev") |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>663246.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>663246.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.8% | Percent of Class Represented by Amount in Row (9)<br>5.8% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** Note to row 6, 8 and 9: 663,246 shares, of which all are directly owned by Bering II.  Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares and Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

---

| 1. | Names of Reporting Persons<br>Philip Sawyer ("Sawyer") | Names of Reporting Persons<br>Philip Sawyer ("Sawyer") |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [x] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>DE | Citizenship or Place of Organization<br>DE |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>663246.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>663246.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>663246.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>5.8% | Percent of Class Represented by Amount in Row (9)<br>5.8% |
| 12. | Type of Reporting Person (See Instructions)<br>IN | Type of Reporting Person (See Instructions)<br>IN |

**Comment for Type of Reporting Person:** Note to row 6, 8 and 9: 663,246 shares, of which all are directly owned by Bering II.  Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares and Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares.

Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024.  With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651.  Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

---

**Item 1(a). Name of Issuer:**
CalciMedica, Inc.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
505 Coast Boulevard South, Suite 307, La Jolla, CA 92037

**Item 2(a). Name of Person Filing:**
This Statement is filed by Bering Partners II, L.P. ("Bering II"), Bering Partners II GP, L.L.C., a Delaware limited liability company ("Bering II GP"), Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer").  The foregoing entities and individuals are collectively referred to as the "Reporting Persons."

Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote and sole power to dispose of shares of the issuer directly owned by Bering II.

Zaytsev and Sawyer are managing members of Bering II GP and may be deemed to have shared power to vote and shared power to dispose of shares of the issuer directly owned by Bering II.

**Item 2(b). Address of Principal Business Office:**
Bering Capital
601 California Street, Suite 620
San Francisco, CA 94108

**Item 2(c). Citizenship:**
Bering II is a Delaware limited partnership.  Bering II GP is a Delaware limited liability company.  Zaytsev and Sawyer are United States citizens.

**Item 2(d). Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**Item 2(e). CUSIP Number:**
38942Q202

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

See Row 9 of cover page for each Reporting Person

**(b) Percent of class:**

See Row 11 of cover page for each Reporting Person

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

See Row 5 of cover page for each Reporting Person

**(ii) Shared power to vote or to direct the vote:**

See Row 6 of cover page for each Reporting Person

**(iii) Sole power to dispose or to direct the disposition of:**

See Row 7 of cover page for each Reporting Person

**(iv) Shared power to dispose or to direct the disposition of:**

See Row 8 of cover page for each Reporting Person

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Under certain circumstances set forth in the limited partnership agreement of Bering II, and the limited liability company agreement of Bering II GP, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a partner or member, as the case may be.

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Bering Partners II, L.P. ("Bering II")**

**Date:** 10/29/2025

**By:** /s/ Evgeny Zaytsev

**Name & Title:** Managing Member of the General Partner

**Bering Partners II GP, L.L.C. ("Bering II GP")**

**Date:** 10/29/2025

**By:** /s/ Evgeny Zaytsev

**Name & Title:** Managing Member

**Evgeny Zaytsev ("Zaytsev")**

**Date:** 10/29/2025

**By:** /s/ Evgeny Zaytsev

**Name & Title:** Evgeny Zaytsev

**Philip Sawyer ("Sawyer")**

**Date:** 10/29/2025

**By:** /s/ Philip Sawyer

**Name & Title:** Philip Sawyer